SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001140361-19-003696
Filing Date
2019-02-22
Accepted
2019-02-22 16:30:46
Documents
11
Effectiveness Date
2019-02-22

Document Format Files

Seq Description Document Type Size
1 DEFM14A s002620x7_defm14a.htm DEFM14A 7569119
2 logo_bristol-myers.jpg GRAPHIC 23955
3 logo_celgene.jpg GRAPHIC 9689
4 logo_evercore.jpg GRAPHIC 11253
5 logo_innisfree4.jpg GRAPHIC 12903
6 logo_morganstanley.jpg GRAPHIC 10201
7 s002620x7_annexg-footer.jpg GRAPHIC 32112
8 s002620x7_proxycard01.jpg GRAPHIC 1329720
9 s002620x7_proxycard02.jpg GRAPHIC 1227678
10 sig_giovannicaforio.jpg GRAPHIC 10130
11 sig_markalles.jpg GRAPHIC 16030
  Complete submission text file 0001140361-19-003696.txt   11065233
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-34912 | Film No.: 19626125
SIC: 2834 Pharmaceutical Preparations